Tavernarakis, I.P
DL declares receipt of grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Pfizer and Sanofi, and past participation in advisory boards and/or receipt of honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Novartis, Pfizer, Sanofi and Shire, outside the submitted work
While the metabolic efficacy of GLP-1RAs is extensively validated, their potential in neuro-ophthalmology is contingent upon their ability to penetrate the blood-brain barrier (BBB) and the BRB
Typical results are increasing GM diversity as in largemouth bass dietary fibers (Lin et al., 2020) and total number of bacteria as in Caspian whitefish ( Rutilus frisii kutum ) (Mirghaed et al., 2018)